Peripheral Signatures of Multidimensional Pathology in Symptomatic and Asymptomatic Creutzfeldt–Jakob Disease
CNS Neuroscience & Therapeutics · 2026
DOI: 10.1002/cns.70765 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Zhong-Yun Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Creutzfeldt-Jakob Syndrome. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Yangfan 3.0" Diagnostic and Therapeutic Capability Enhancement Project of Beijing Municipal Hospital Administration, 2.High-Level Public Health Technical Talent Development Project, 3.Capital's Funds for Health Improvement and Research.
Abstract (Originalsprache)
Background
Plasma markers of neuronal injury in Creutzfeldt–Jakob disease (CJD) are established, but peripheral biomarkers reflecting glial activation, synaptic dysfunction, and vascular impairment remain less explored. We systematically assessed these markers in symptomatic CJD and asymptomatic PRNP mutation carriers to improve diagnosis and identify early pathophysiology.
Methods
This prospective cohort study recruited CJD, frontotemporal dementia (FTD), healthy controls (HCs), and preclinical familial CJD pedigrees. Sixteen plasma proteins representing neuronal injury, glial activation, synaptic function, and vascular/BBB integrity were measured. Analyses included group differences, discriminative performance, clinical/imaging correlations, and longitudinal trajectories.
Results
We enrolled 130 CJD patients, 145 FTD, 70 HCs, 16 asymptomatic PRNP carriers (4–6 years follow‐up, 4 converters), and 16 non‐carrier family controls. In symptomatic CJD, plasma NfL, t‐tau, and GFAP were strongly elevated, each showing excellent discriminative performance (AUCs > 0.93 vs. HCs and > 0.82 vs. FTD). We also observed alterations in vascular/BBB markers, with VCAM‐1 levels elevated and significantly associated with both clinical decline and DWI hyperintensity. In asymptomatic carriers, biomarker levels remained largely normal and stable preclinically. Notably, two G114V carriers showed mild pre‐symptomatic elevations in NfL and GFAP, and one exhibited a slight VCAM‐1 increase before clinical onset; all changes exceeded the 90th percentile of control values. E200K and T188K carriers showed no pre‐onset changes.
Conclusions
Plasma biomarkers in CJD may reflect multisystem involvement, with neuronal markers showing strong discriminative potential and vascular proteins indicating possible BBB dysfunction. In asymptomatic carriers, minor changes may occur only near onset in those with relatively slow‐progressing mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Zhong-Yun Chen, Min Chu
Förderung
- "Yangfan 3.0" Diagnostic and Therapeutic Capability Enhancement Project of Beijing Municipal Hospital Administration
- 2.High-Level Public Health Technical Talent Development Project
- 3.Capital's Funds for Health Improvement and Research
- 4.National Natural Science Foundation of China
Zitieren
APA
Chen, Z. Y., Chu, M., Wang, Y. H., Liu, R., Zhang, J., Yue, A. L., Lu, H., He, Q. Q., Hou, J. H., Chen, Y. F., Ye, H., & Wu, L. Y. (2026). Peripheral Signatures of Multidimensional Pathology in Symptomatic and Asymptomatic Creutzfeldt–Jakob Disease. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70765
Vancouver
Chen ZY, Chu M, Wang YH, Liu R, Zhang J, Yue AL, et al. Peripheral Signatures of Multidimensional Pathology in Symptomatic and Asymptomatic Creutzfeldt–Jakob Disease. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70765
BibTeX
@article{Chen2026,
author = {Chen, Zhong-Yun and Chu, Min and Wang, Yi-Hao and Liu, Rui and Zhang, Jing and Yue, Ai-Ling and Lu, Hua and He, Qian-Qian and Hou, Jia-Hui and Chen, Yu-Fei and Ye, Hong and Wu, Li-Yong},
title = {Peripheral Signatures of Multidimensional Pathology in Symptomatic and Asymptomatic Creutzfeldt–Jakob Disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
doi = {10.1002/cns.70765}
}
EUVIMED